Structural Reform at the FDA: Can FDA Become a High Performance Organization?

Abstract

This paper shares some of the management challenges we face at the Food & Drug Administration (FDA) and how we are addressing them. The FDA is undergoing more substantive change than at any time in its recent history. I would like to provide an overview of some of those changes. I come to the FDA with a private sector background. Within the private sector, the emerging management model of the 1990s is one of high performance organizations. Within the public sector there exists an equally important imperative to create such high performance organizations. I would like to share with you steps we are taking at the FDA to improve our internal management and operations.